A disintegrin and metalloproteinase 17 (ADAM17), a type I transmembrane metalloproteinase, mediates the shedding of several transmembrane proteins in the extracellular domain and is associated with various diseases, such as atherosclerosis, adipose tissue metabolism, insulin resistance and diabetes.10 Here, ADAM17 is linked to atherosclerosis.